A new funding source for life sciences startups? Looks like investment firm Foresite Capital is raising a new fund – to the tune of $450 million.
Hat tip to Fortune‘s Dan Primack for this one:
“New fund alert: Healthcare growth equity firm Foresite Capital is nearing a final close on its third fund, which is expected to hit its $450 million hard cap, according to a source familiar with the situation. This comes just over one year since Foresite announced that it had raised $300 million for its second fund. Portfolio companies include Aduro BioTech, Intarcia Therapeutics, Sequenta and Zafgen. No comment from the firm, natch.”
Help employers find you! Check out all the jobs and post your resume.
